Many mobile applications (apps) for type 1 and 2 diabetes management incorporate results from BGMSs, however there is a paucity of evidence demonstrating benefits of apps for hypoglycemia management. Hypoglycemia management is associated with the performance of BGMSs in low blood glucose range (LBGR) and any app reliant on BG results is subsequently dependent. Previously we presented data demonstrating a reduced risk of hypoglycemia associated with the use of the CONTOUR®DIABETES app (CDA) whilst utilizing CONTOUR®NEXT ONE BGMS (CNO). Here we study the possible variation of hypoglycemia detection if BGMSs other than CNO were used with the app to obtain BG readings
All BGMSs were assessed for the likelihood of results ±15% of reference BG value of 50 mg/dl (CI 95%). We assumed that all assessed BGMSs were used with the app and all BG readings were analyzed identically as it has been performed in the CDA study using CNO.
The probability of achieving ±15% of reference BG value of 50 mg/dl of some BGMSs were below 95% (Figure 1) and LL of BG readings of one BGMS (ACAC) were >50 mg/dl.
Not all BGMSs utilizing apps are capable of detecting hypoglycemia with a high probability thus not leading to potential reduced hypoglycemia occurrence as previously demonstrated. This analysis demonstrates that the selection of BGMS is critical in assessing the effectiveness of apps on glycemic control and particularly hypoglycemic management.